RPL7AP33

Across TCGA pan-cancer cohorts, RPL7AP33 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL7AP33’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RPL7AP33 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL7AP33 is over-expressed in tumor.

LUSC, LUAD, and LIHC are the cancer types where RPL7AP33 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL7AP33 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	All	+0.079	.005	3	view →
LUAD	All	All	+0.050	.019	3	view →
LIHC	All	All	+0.027	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL7AP33–LUSC

Open the LUSC breakdown →